Skip to main content
. 2016 Jun;22(6):10.18553/jmcp.2016.22.6.723. doi: 10.18553/jmcp.2016.22.6.723
Variable Estimate Standard Error T Value P Value
Intercept 164.054 9.316 17.61 < 0.0001
Gender (female vs. male) -20.628 8.251 -2.500 0.013
Geography
Midwest vs. Northeast -27.978 10.763 -2.60 0.010
West vs. Northeast -27.710 11.456 -2.42 0.016
South vs. Northeast -10.709 9.959 -1.08 0.282
Unknown vs. Northeast 156.946 122.997 1.28 0.202
Prior regimen
Everolimus vs. sunitinib 18.188 9.619 1.890 0.059
Pazopanib vs. sunitinib -2.983 9.865 -0.300 0.762
Temsirolimus vs. sunitinib -31.320 14.791 -2.120 0.034
Other vs. sunitinib -46.400 16.075 -2.890 0.004
Sorafenib vs. sunitinib -3.385 19.412 -0.170 0.862
Bevacizumab vs. sunitinib -50.226 22.874 -2.200 0.028
Baseline hypothyroidism treatment (yes vs. no) 25.538 8.927 2.860 0.004